Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,526 | 56,617 | 57,765 | 112,975 | 34,522 |
| Marketable Securities | 177,161 | 198,843 | 232,592 | 225,728 | 240,736 |
| Receivables | 20,473 | 23,604 | 22,809 | 15,828 | 24,790 |
| Other current assets | 13,774 | 23,330 | 23,496 | 27,297 | 20,403 |
| TOTAL | $278,001 | $313,396 | $346,683 | $395,418 | $334,971 |
| Non-Current Assets | |||||
| PPE Net | 117,589 | 120,551 | 123,969 | 127,662 | 132,103 |
| Investments And Advances | 10,179 | 23,108 | 36,943 | 41,807 | 38,871 |
| Other Non-Current Assets | 60,220 | 62,059 | 61,784 | 64,328 | 68,025 |
| TOTAL | $187,988 | $205,718 | $222,696 | $233,797 | $238,999 |
| Total Assets | $465,989 | $519,114 | $569,379 | $629,215 | $573,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,798 | 19,522 | 16,362 | 31,356 | 22,786 |
| Accrued Expenses | 38,070 | 48,642 | 42,488 | 33,129 | 49,703 |
| Other current liabilities | 34,309 | 26,697 | 32,100 | 38,615 | 50,567 |
| TOTAL | $103,194 | $102,725 | $98,273 | $110,179 | $130,272 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 115 | 144 | 21 | 13 | 148 |
| Other Non-Current Liabilities | 103,144 | 114,973 | 122,839 | 128,370 | 131,956 |
| TOTAL | $103,144 | $114,973 | $122,839 | $128,370 | $131,956 |
| Total Liabilities | $206,338 | $217,698 | $221,112 | $238,549 | $262,228 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,086 | 49,545 | 49,423 | 49,256 | 44,428 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -932,149 | -880,963 | -821,366 | -768,377 | -705,047 |
| Other shareholders' equity | -741 | -582 | -2,266 | -3,229 | -4,429 |
| TOTAL | $259,651 | $301,416 | $348,267 | $390,666 | $311,742 |
| Total Liabilities And Equity | $465,989 | $519,114 | $569,379 | $629,215 | $573,970 |